2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z

Back Muscle Activity is Associated with Pain with Cervical Dystonia Patients

R. Ortiz, M. Moisala, P. Maunu, J. Honkaniemi (Turku, Finland)
Balance assessment and effect of virtual reality in Hereditary Spastic Paraplegia

M. Severiano, G. Dos Santos, C. de Araújo, F. Gonçalves, B. Zeigelboim, H. Teive (Curitiba, Brazil)
Balance biomarker for early differentiation of Parkinson’s disease and multiple system atrophy with parkinsonian type

HJ. Chang, JH. Kim, S. Lee, E. Kwon, SH. Jeong, E. Oh (Daejeon, Republic of Korea)
Balance confidence may not accurately assess fall risk in atypical parkinsonism

G. Arleth, E. Buxton, R. Bryant, M. Ivancic, N. Browner, J. Shurer, M. Sklerov (Chapel Hill, USA)
Barriers and Facilitators of Adherence to Mediterranean-Ketogenic and MCT-Supplemented Mediterranean Diets in Parkinson’s Disease: A Qualitative Secondary Analysis from a Random-Order Crossover Trial

K. Tosefsky, Y. Wang, J. Lam, A. Kuan, S. Appel-Cresswell (Vancouver, Canada)
Barriers to Healthcare Utilization and Adherence to Medications among People Living with Parkinson’s Disease in Senegal

M. Njohjam, M. Fall, F. Niakam, J. Kahwagi, A. Diop, M. N, A. Diop (Dakar, Senegal)
Barriers To Physical Exercise Adherence In Individuals With Parkinson’s Disease: A Cross-Sectional Study

S. Souza, G. Leveck, T. Christinelli, L. Paladini, V. Israel (Curitiba, Brazil)
Basal Ganglia Neurophysiological Activity Associated with Depression in Parkinson’s Disease

K. Johnson, P. Coutinho, L. Kenney, J. Wong, J. Hilliard, K. Foote, D. Bowers, G. Pontone, C. de Hemptinne (Gainesvile, USA)
Basal Ganglia Physiomarkers of Non-motor Symptoms in Parkinson’s Disease: a Systematic Review

B. Keulen, M. Beudel, A. Malekzadeh, R. de Bie, B. Swinnen (Amsterdam, Netherlands)
Baseline brain inflammation is associated with less cognitive progression at 24 months in subjects with de novo Parkinson’s disease

T. Yacoubian, N. Stover, M. Dean, A. Amara, L. Ruffrage, H. Qin, E. Benveniste, Y. Fang, J. Mcconathy, Y. Zhang, R. Kennedy, A. Gerstenecker, D. Standaert (Birmingham, USA)
Baseline cerebrospinal levels of p-tau and amyloid beta and striatal dopamine transporter binding predict mild cognitive impairment and dementia diagnosis in Parkinson’s disease

L. Collins-Praino, A. Mcnamara, I. Baetu (Adelaide, Australia)
Bassoon (BSN) Gene Mutations: A Missing Link in Gait and Balance Dysfunction Across Parkinsonian Disorders?

P. Kukkle, A. Kaladiyil, T. Geetha, R. Menon, R. Kandadai, V. Goyal, S. Desai, D. Joshi, H. Kumar, P. Wadia, A. Mukherjee, N. Kumar, S. Mehta, S. Chargulla, S. Murugan, H. Shah, V. Paramanandam, M. Chandran, R. Yadav, R. Dhamija, P. Pal, A. Biswas, R. Gupta, R. Borgohain, V. Ramprasad (Bengaluru, India)
Bayesian Re-Analysis of Phase I and II Subthalamic Nucleus Perfusion Changes Following Mesenchymal Stem Cell Infusion in Parkinson’s Disease

T. Thomas, T. Ellmore, E. Tharp, J. Martinez-Lemus, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte Rascon, R. Ritter Iii, M. Schiess (Houston, USA)
Beta-band power predicts fatigue scores in Parkinson’s Disease: a qEEG study

JP. Romero, A. Hurtado, F. Sanchez Cuesta, M. Moreno Verdu, M. Martín Buró (Madrid, Spain)
Beyond “benign”, tremor and epilepsy in FAME3-A New Family Report with Progressive Course and Cognitive Impairment

D. Campo-Caballero, F. Magrinelli, M. Carazo, M. Maneiro, A. Vinagre-Aragón, E. Mondragón, A. Gabilondo, J. Ruiz-Martínez, L. Blázquez, H. Houlden, P. Iruzubieta (San Sebastian, Spain)
Beyond Medication: The Potential of Diet in Parkinson’s Management

G. Hitawala, L. Shulman (Baltimore, USA)
Beyond Motor Symptoms: The Interplay Between Non-Motor Symptoms and Caregiver Challenges in Late-Stage Parkinson’s Disease

D. Shah, A. Kothiala, D. Christian (Ahmedabad, India)
Beyond Neurodegeneration: Anti-Recoverin Autoantibodies in Immune-Mediated Parkinsonism

A. Sultana, N. Anam, S. Kamat, F. Ansari, A. Vyas, S. Wagh (Mumbai, India)
Beyond the basal ganglia: acute hemiballismus secondary to a parietal stroke

B. Maliszewski, H. Crosby, A. Samara, S. Keyrouz, D. Di Luca (Saint Louis, USA)
Beyond the Classic Triad: An Unusual Phenomenology of Parkinsonism in a Patient with Superficial Siderosis (SS)

D. Sblendorio, J. Frey (Morgantown, USA)
Beyond UPDRS: personalizing the assessment of different DBS modes

S. Marceglia, IU. Isaias, L. Borellini, E. Mailland, F. Cogiamanian, R. Ferrucci, M. Arlotti, L. Rossi, S. Bonvegna, C. Palmisano, L. Caffi, G. Pezzoli, M. Locatelli, A. Priori (Milan, Italy)
Biallelic Variants in ACER3 Encoding Alkaline Ceramidase 3 Cause Infantile- and Early-Childhood-Onset Neurodegeneration with Progressive Leukodystrophy

R. Kaiyrzhanov, A. Study Group, H. Houlden, R. Maroofian (Shymkent, Kazakhstan)
Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review

K. Orayj (Abha, Saudi Arabia)
Bidirectional Relationships Between Frailty and DNAm Age Acceleration and its Mediation Effects on Physical Disability and Mortality

C. Han, J. Chhetri, P. Chan (Beijing, China)
Bilateral Pallidal Deep Brain Stimulation in Secondary Dystonia in Louis-Bar-Syndrome Patients – A Report of Two Cases-

N. Warneke, I. Claus, V. Zentsch, W. Stummer (Münster, Germany)
Biological Characteristics of Individuals with RBD: A Multicenter Prospective Longitudinal Cohort

J. Feuerstein, E. Brown, L. Chahine, C. Gochanour, D. Lafontant, M. Marshall, T. Simuni, D. Weintraub (Aurora, USA)
Biomarker Panels for Parkinson’s Disease using Multi-Omics Approach: Recent Developments and Future Directions

PRA. Sharma, RK. Dhamija (Delhi, India)
Blepharospasm as cause of facial pain and “sinus” headache: A case series

J. Anang (Winnipeg, Canada)
Blinded video-based analysis of dystonia before and after unilateral High Intensity Focused Ultrasound thalamotomy in Essential and Dystonic Tremor

J. Peters, J. Maamary, K. Kyle, I. Osborne, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)
Blood and CSF Biomarkers of Cognitive Impairment in Alpha Synucleinopathies

C. Girges, N. Vijiaratnam, N. O’Reilly, J. Hay, V. Chelban, D. Athauda, H. Morris, H. Houlden, S. Gandhi, T. Foltynie (London, United Kingdom)
Blood levels of Cathepsin B are linked to a reduced risk of Parkinson’s disease

X. Guo, R. Li (Xi'an, China)
Blood-based biomarkers for diagnosis and prediction of Parkinson’s Disease in GBA1 individuals

M. Avenali, L. Bandirali, S. Caminiti, P. Mitrotti, L. Gallo, R. Stiuso, R. Calabrese, G. Cuconato, C. Galandra, C. Tassorelli, S. Cerri, EM. Valente, F. Blandini (Pavia, Italy)
Blood-based somatic CAG repeat expansion and clinical progression in Huntington’s disease patients from Western China

SR. Zhang, YF. Cheng, CY. Li, HF. Shang (Chengdu, China)
Bodily Maps of Symptoms and Emotions in Dystonia

K. Niemi, E. Ottela, A. Huovinen, E. Glerean, L. Nummenmaa, E. Jaakkola, J. Joutsa (Turku, Finland)
Body Composition and Resting Metabolic Rate in Parkinson’s disease-A Cross Sectional Study

F. Mk, S. Prasad, T. Nagaraj, S. Bhat, M. Bhardwaj, DK. Samartha, P. Mailankody, R. Mahale, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Bone Mineral Density in Early Parkinson’s Disease: Correlations with Disease Severity and Prognosis

MG. Choi, SY. Jo, JY. Lee, SJ. Chung (Seoul, Republic of Korea)
Boosting Education and Awareness Together for people with Parkinson’s Disease (BEATs-PD): Methodological Considerations in Research Co-Creation

R. Khamishon, K. Devlin, B. Advisory Board, K. Kang, L. Currens, E. Lu, S. Phelan, E. Choi, S. Willoughby, A. Pantelyat, K. Mills (Baltimore, USA)
Boosting the LTP-like Plasticity Effect of Intermittent Theta-burst Stimulation with Gamma Transcranial Alternating Current Stimulation improves Bradykinesia in Parkinson’s Disease

G. Paparella, D. Costa, M. de Riggi, L. Angelini, A. Cannavacciuolo, S. Pietracupa, A. Berardelli, A. Guerra, M. Bologna (Pozzilli
Botulinium toxin in treatment of Parkinsonism

A. Wankar (Nagpur, India)
Botulinum toxin therapy in patients with Hemifacial spasm: beyond the treatment of motor symptoms.

MB. Charra Castellani, MV. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)
Brain Cholinergic Changes in Progressive supranuclear palsy: A single-subject voxel-wise approach to understanding heterogeneity

P. Kanel, G. Carli, J. Barr, R. Vangel, A. Narkis, C. Spears, P. Scott, R. Albin, N. Bohnen (Ann. Arbor, USA)
Brain Energetics: Changes in Healthy Aging and Parkinson’s Disease

C. Bevington, S. Dhaliwal, J. Mckenzie, A. Stoessl, V. Sossi (Vancouver, Canada)
Brain hemodynamic responses to a motor control paradigm in younger and older adults, and people with Parkinson’s Disease: An fNIRS mediated feasibility study.

M. Bjalme-Evans, K. Heffernan, D. Wani, S. Leung, J. Carter, A. Bowden, A. Raghunathan, L. Quinn (New York, USA)
Brain perfusion patterns associated with motor symptoms in multiple system atrophy

Y. Nakano, A. Sugiyama, S. Hirano, Y. Nakagawa, M. Tamura, T. Yamamoto, Y. Koizumi, Y. Suzuki, K. Yamagishi, Y. Chishiki, S. Kuwabara, Y. Kitayama (Chiba, Japan)
Brain Structural Impairment in Spinocerebellar Ataxia Type 6: Not Restricted to the Cerebellum

B. Massuyama, T. Rezende, M. Junior, O. Barsottini, J. Pedroso (Campinas, Brazil)
Brain Target Engagement and Pharmacokinetic-Enzyme Occupancy (PK-EO) Relationship of FNP-223: A Novel Oral OGA Inhibitor for Progressive Supranuclear Palsy – Phase 1 PET Study

R. Pokorny, J M. Ryan, E. Rabiner, G. Searle, C. Varona, M. Schneider, C. Wiessner, J F. Stallaert, B. Permanne, A. Quattropani, D. Beher (Lausanne, Switzerland)
Brainstem Subsegmentation in Spinocerebellar Ataxia Type 3 (SCA3)

K. Teichmann (Bonn, Germany)
Breaking Away From the Ivory Tower

J. de (Kogarah, Australia)
Bridging the Care Gap for Individuals with Drug-Induced Movement Disorders Using Telemedicine: A Randomized Pilot Study

E. Houston, A. Kennedy, T. Rabinowitz, G. Rose, J. Boyd (Burlington, USA)
Bridging the Digital Gap: A Global Survey of Technology Adoption by the MDS Technology Study Group

S. Hirczy, H. Sarva, S. Paul, A. Lane, C. Antoniades, W. Maetzler, A. Mirelman, R. Schneider, J. Hausdorff, J. Vizcarra, J. Klucken, M. Monje, M. Mancini, P. Bonato, A. Nieuwboer, F. Horak, L. Rochester, A. Sanchez-Ferro, M. Fabbri, T. Mestre, R. Reilmann, A. Espay, B. Bloem, R. Bhidayasiri, A. Pilotto (Dallas, USA)
Broad spectrum local field potential activities as a novel biomarker for adaptive deep brain stimulation

CH. Tai, YC. Lin, WH. Hu, MT. Hsu, SH. Tseng (Hsinchu, Taiwan)
Building Genetic Counseling Capacity in Latin America: The PD GENEration–LARGE-PD Training Framework

V. Caceres, R. de León, M. Inca Martinez, I F. Mata, A. Coral, P. Hodges (Indianapolis, USA)
Bulbar Symptoms Precede Diagnosis in Early-Onset, but not in Typical- to Late-Onset Friedreich Ataxia: Real-World Data From Medical Claims

S. Kuo, S. Nayar, B. Bian, D. Gomes, S. England, J. Mckay, T. Wang, R. Avila, S. Perlman (New York, USA)
Burden and Resilience Among Rural Caregivers of Persons with Parkinson’s Disease

R. Smith, L. Sancho, J. Calhoun, A. Gallentine, M. Matthiesen, C. Steim, E. Stegemöller (Ames, USA)
Burden of Non-Motor Manifestations in Huntington’s disease patients – A cross-sectional study in a teaching hospital in India.

M. Prathyusha, D. Radhakrishnan (New Delhi, India)

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z